Results 131 to 140 of about 6,241 (179)

WDFY4-dependent cross-presentation proceeds via a vacuolar antigen-processing route. [PDF]

Proc Natl Acad Sci U S A
Postoak JL, Koch A, Shan S, Ohara RA, Jo S, Chen J, Desai P, Ou F, Kraft M, Diamond MS, Kim S, Murphy TL, Murphy KM.   +12 more
europepmc   +1 more source

Microwave ablation combined with dendritic cells enhances CD8⁺ T cell activation in rechallenged tumor mouse model. [PDF]

Cancer Immunol Immunother
Ma J, Xu F, Wang M, Zhang S, Sang J, Chen H, Wen F, Ge R, Xie Q, Wei Z, Ye X.   +10 more
europepmc   +1 more source

Inhibitory PD-1 axis maintains high-avidity stem-like CD8⁺ T cells. [PDF]

Nature
Hor JL, Schrom EC, Wong-Rolle A, Vistain L, Shang W, Dong Q, Zhao C, Jin C, Germain RN.   +8 more
europepmc   +1 more source

Myeloid-driven immunosuppression in head and neck cancer: single-cell ATAC/RNA and spatial transcriptomic perspectives. [PDF]

Front Oncol
Luo R, Yang J, Cao Z, Li B.
europepmc   +1 more source

Dual-receptor targeting of type I dendritic cells with DNA-scaffolded nanoparticles enhances STING-licensed antitumor immunity. [PDF]

Sci Adv
Jana D, Herdes E, Moustouka J, Mash KM, Chen J, Ebeid K, Sallam M, Abbasi A, Desai T.   +8 more
europepmc   +1 more source

Chronic inflammation-responsive hydrogel restores myeloid-T cell crosstalk to reinvigorate antitumor immunity against metastatic colorectal cancer. [PDF]

Bioact Mater
Li X, Fu W, Le H, Luo R, Li Y, Kou X, He T, Bai L, Xu Y, Cao J, Wang Y, Yu X, Mi P, Luo Z, Gong C.   +14 more
europepmc   +1 more source

Erythropoietin receptor on cDC1s dictates immune tolerance. [PDF]

Nature
Zhang X, McGinnis CS, Yu G, Chen S, Zheng P, Schürch CM, Hiam-Galvez KJ, Reticker-Flynn NE, Guo W, Yao W, Qiu J, Muselman A, Linde IL, Hickey JW, Yan H, Tran VM, Qiu W, Brichart-Vernos D, Hirai T, Yu B, An X, Xiao Y, Paidassi H, Scharschmidt TC, Angelo M, Sheppard D, Chi H, Satpathy AT, Way SS, Malissen B, Strober S, Engleman EG.   +31 more
europepmc   +1 more source

CD40 agonist improves the therapeutic efficacy of irreversible electroporation ablation for metastatic melanoma by promoting unexpected CD8⁺CD103⁺ cDC1 and TRM cell responses. [PDF]

Cancer Immunol Immunother
Wu Z, Yang Z, Iftikhar T, Groot G, Leary SC, Baniak N, Ahmed S, Bosch M, Moser M, Zhang W, Jiang J, Xiang J.   +11 more
europepmc   +1 more source

Chemokine-chemokine receptor networks in conventional type I dendritic cells: an opportunity to prime and boost anticancer immunity. [PDF]

J Pharmacol Exp Ther
Kuo N, Shinn CK, Schokrpur S, Idoyaga J, Handel T, Gutkind JS.   +5 more
europepmc   +1 more source

The Role of Plasmacytoid Dendritic Cells in the Immune Contexture of <i>TP53</i>-Mutated High-Grade Serous Ovarian Cancer. [PDF]

Cancers (Basel)
Steger K, Fiegl H, Rungger K, Leitner K, Tsibulak I, Feroz B, Ebner C, Marth C, Hackl H, Zeimet AG.   +9 more
europepmc   +1 more source